ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Allogene Therapeutics Inc

Allogene Therapeutics Inc (ALLO)

1.95
0.08
(4.28%)
Closed 24 December 8:00AM
1.95
0.00
(0.00%)
After Hours: 10:56AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 47k52k44k43k-44k22k00
Operating Income -96.37M-99.07M-80.52M-62.98M-71.93M-69.5M-71.43M-71.77M
Pre Tax Income -94.85M-98.7M-77.99M-61.32M-89.26M-65M-66.36M-66.29M
Net Income -94.85M-98.7M-77.99M-61.32M-89.26M-65M-66.36M-66.29M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -97.6M-100.76M-81.77M-64.52M-78.28M-69.5M-72.28M-72.9M
EBITDA -93.3M-95.56M-76.88M-59.4M-68.45M-65.95M-62.8M-57.84M
Year End 31 December 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000038.49M243k95k
Operating Income -2k-192.84M-202.01M-258.24M-255.79M-335.45M-314.49M
Pre Tax Income -2k-211.62M-184.93M-250.22M-257.01M-332.63M-327.27M
Net Income -2k-211.51M-184.59M-250.22M-257.01M-332.63M-327.27M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) 0-1.741-1.485-1.781-1.802-2.303-1.945
EBIT -2k-214.05M-202.28M-259.39M-258.72M-337.2M-325.33M
EBITDA -2k-191.34M-196.81M-250.66M-245.34M-321.15M-300.29M